Need for a more correct estimate of biological variation values

Biochimica Clinica

Volumn 35, Issue 5, 2011, Pages 382-385

  Franzini, Carlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; CHOLESTEROL; CREATINE KINASE MB; GLUCOSE; HAPTOGLOBIN; HYDROCORTISONE; IMMUNOGLOBULIN G; IRON; LACTIC ACID; LIOTHYRONINE; LUTEINIZING HORMONE; MAGNESIUM; POTASSIUM; PROLACTIN; SODIUM; TESTOSTERONE; THYROTROPIN; THYROXINE; TISSUE POLYPEPTIDE ANTIGEN; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOLOGICAL MONITORING; BIOLOGICAL VARIATION VALUE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOGLOBULIN BLOOD LEVEL; IRON BLOOD LEVEL; LACTATE BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; NOTE; POTASSIUM BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RELIABILITY; SODIUM BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 83655164571     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (20)

1. Hyltoft Petersen P, Fraser CG, Kallner A, et al. Strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:475-585.
2. Mina A. A new quality control model using performance goals based on biological variation in external quality assurance schemes. Clin Chem Lab Med 2006;44:89-91.
3. Biological variation database specifications. Desirable specifications for total error, imprecision, and bias derived from intra- and inter-individual biologic variation. Madison, USA: Westgard QC, 2011. http://www.westgard.com/ biodatabase1.htm
4. Lacher DA, Hughes JP, Carrol MD. Estimate of biological variation of laboratory analytes based on the Third National Health And Nutrition Examination Survey. Clin Chem 2005;51:450-2. (Pubitemid 40175818)
5. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subject: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8. (Pubitemid 27024390)
6. Franzini C. Need for correct estimates of biological variation: the example of C-reactive protein. Clin Chem Lab Med 1998;36:131-2.
7. Melzi d'Eril GV, Tagnochetti T, Nauti A, et al. Biological variation of N-terminal-pro-brain natriuretic peptide in healthy individuals. Clin Chem 2003;49:1554-5. (Pubitemid 37011755)
8. Pagani F, Stefini F, Panteghini M. Biological variation in serum concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP). Clin Chem 2003;49:A34.
9. Besozzi M. Un problema in tema di variabilità biologica, variabilità analitica e differenze critiche. Biochim Clin 1994;18:307-12.
10. Dimitri G. "Critical difference" and biological variation of serum triglycerides. Clin Chem 1994;40:501. (Pubitemid 24097823)
11. Grossi E, Colombo R, Cavuto S, et al. Age and gender relationships of serum alanine aminotransferase values in healthy subjects. Am J Gastroenterol 2006;101:1675-6. (Pubitemid 43980650)
12. Fokkema MR, Herrmann Z, Muskiet FAJ, et al. Reference change values for brain natriuretic peptide revisited. Clin Chem 2006;52:1602-3. (Pubitemid 44148325)
13. Haeckel R, Wosniok W. Observed, unknown distributions of the clinical chemical quantities should be considered to be log-normal: a proposal. Clin Chem Lab Med 2010;48:1393-6.
14. Braga F, Dolci A, Mosca A, et al. Variabilità biologica dell'emoglobina glicata: un'analisi sistematica della letteratura. Biochim Clin 2009;33:297-302.
15. Ricos C, Iglesias N, Garcia-Lario J-V, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343-52. (Pubitemid 351724670)
16. Borsotti M, Quercioli M, Franzini C. Criteri per la selezione dei limiti di accettabilità dei risultati nei programmi di Valutazione Esterna della Qualità. Biochim Clin 2008;32:260-8.
17. Carobene A, Franzini C, Ceriotti F. Traguardi analitici per VEQ: due programmi a confronto. Biochim Clin 2010;34:607-11.
18. Braga F, Dolci A, Montagnana M, et al. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system. Clin Chim Acta 2011;412:1412-6.
19. Bartlett B. Biological variation data: the need for appraisal of the evidence base. Presented at the IFCC-WorldLab-EuroMedLab Berlin 2011. May 18, 2011, Berlin, Germany. Available at: http://biologicalvariation.com/ESW/Files/ BERLIN-final-2011PD.pdf
20. Jones J, Chen L-S, Baudhuin L, et al. Relationships between C-reactive protein concentration and genotype in healthy volunteers. Clin Chem Lab Med 2009;47:20-5.